Knowledge Hub

Theme

Doc type

Theme

Doc type

No matches found. Perhaps try different keywords or explore our categories.

FACT SHEET – InflammaSkin^®: Anti-psoriasis efficacy testing for topical & injectable drugs

2 November 2026

...

POSTER – Scalp inflammation with a human hair follicle-preserving model

25 September 2026

...

POSTER – Advancing psoriasis research with InflammaSkin^®

25 September 2026

...

POSTER – Improving Clinical Translation Through Human Skin-Based New Approach Methodologies

17 September 2026

...

POSTER – Advancing mast cell research with a standardized human primary cell platform

1 September 2026

...

POSTER – Longitudinal maintenance of human skin viability in HypoSkin^®

1 September 2026

...

POSTER – Human primary mast cells as an advanced model for drug development

1 September 2026

...

WEBINAR #16 – Neuroimmune circuits in allergic immunity

25 August 2026

...

Mast cell depletion mechanisms: from biological rationale to human-relevant testing

28 July 2026

...

PRESS RELEASE – Genoskin expands access to Primary Human Mast Cells across North America

29 June 2026

Genoskin is pleased to announce that its primary human mast cells will now be available to customers in North America, marking a key milestone in the ...

Genoskin at MPS 2026

13 May 2026

...

FACT SHEET – WoundSkin^®: Advance your wound healing research

27 April 2026

...

PRESS RELEASE – Genoskin appoints new board member to strengthen governance

27 April 2026

Genoskin strengthens governance with appointment of industry leader Fabrice Bouteille, a strategic milestone reinforcing independence, global growth, ...

POSTER – SOT HypoSkin Pharma Latch

26 March 2026

...

POSTER – SOT Hyposkin argenx

26 March 2026

...

PRESS RELEASE – Genoskin collaboration with argenx

18 March 2026

At the 2026 annual meeting of the Society Of Toxicology (SOT), we will present new data demonstrating the value of our HypoSkin® ex vivo human skin ...

WEBINAR #15 – Preclinical evaluation of an energy-driven device for localized skin delivery of nucleic acids

17 February 2026

...

APPLICATION NOTE – NativeSkin^® & UV testing

2 February 2026

Explore how NativeSkin® supports ethical, human-relevant, and translational research in UV testing, phototoxicity assessment, and photobiology. ...

Rethinking wound healing: from classical readouts to emerging ways of studying tissue repair

29 January 2026

...

Beyond clean claims, the emergence of skin microbiome in skin care

16 January 2026

...

WEBINAR #14 – Decoding human skin wound healing

19 December 2025

...

APPLICATION NOTE – Toxicity services for pharma, biotech & medical devices developers

22 October 2025

Download this application note and discover 3 case studies. Refine formulations or assess local tolerance in human skin before clinical trials. ...

WEBINAR #13 – Evolving Insights into the Role of Mast Cells in Anaphylaxis

6 October 2025

...

POSTER – Development of a Mast Cell Depleting Antibody for the Treatment of Mastocytosis

25 September 2025

...

PRESS RELEASE – Genoskin raises series A to advance human-based drug development

16 September 2025

We are excited to announce that Genoskin, a leader in developing ex vivo human skin platforms for testing drugs and medical devices, has raised $8.7 ...

WHITE PAPER – HypoSkin^® & immunogenicity testing

10 September 2025

Explore how HypoSkin®—a standardized, injectable, and immunocompetent human skin model—provides a translational, animal-free solution for ...

WEBINAR #12 – Drug-specific antibody repertoires from allergics: a source of therapeutics?

26 August 2025

...

APPLICATION NOTE – NativeSkin^® & Pharma

20 May 2025

Explore how NativeSkin® supports ethical, human-relevant, and translational research for pharma. ...

WEBINAR #11 – From defense to disease: how Type 2 immunity shapes skin health

20 May 2025

...

APPLICATION NOTE – VaxSkin^®, an innovative platform to study vaccine immunogenicity

9 April 2025

...

Advancing medical device development with ex vivo human skin

2 April 2025

...

APPLICATION NOTE – NativeSkin^® & Cosmetics

18 March 2025

Explore how NativeSkin® supports human-relevant cosmetic efficacy and safety testing, helping you strengthen claims and de-risk formulations earlier. ...

Beyond animal models: The role of human skin in ADME testing

13 March 2025

...

The future of vaccine research

10 March 2025

...

WEBINAR #10 – Subcutaneous administration of vesicant/irritant anticancer drugs from water-soluble polymer prodrugs

4 March 2025

...

FACT SHEET – HairSkin, Human skin model with hair follicles

17 February 2025

...

From human skin to human data: Advancing immunogenicity testing with human models

10 February 2025

...

WEBINAR #9 – The NLRP1 Inflammasome Etienne Meunier

28 January 2025

...

Top things found in human skin!

16 December 2024

...

APPLICATION NOTE – T cell activation and flow cytometry

19 November 2024

This application note highlights new comparative data on T cell dynamics in HypoSkin^® and InflammaSkin^®, generated using flow ...

PROTOCOL – NativeSkin^® Analyses

19 November 2024

...

Discover how VaxSkin can transform your vaccine development

6 November 2024

The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. ...

WHITE PAPER – HypoSkin^® validation data

21 October 2024

In this white paper, discover new validation data demonstrating the stability, injectability and immunocompetency of our HypoSkin^® model. ...

POSTER – Single-cell profiling of biostabilized natural human skin identifies mast cells as an important target of injected mRNA-1273 COVID-19 vaccine

14 October 2024

...

POSTER – HypoSkin^®, a new model to study microbiome

14 October 2024

...

POSTER – Woundskin^®, an innovative model to study wound healing

14 October 2024

Genoskin presents WoundSkin^®, an infected wounded ex vivo skin model suited to assess the efficacy of wound-healing formulations. ...

POSTER – NativeSkin^®, maintaining skin integrity and metabolism

14 October 2024

...

POSTER – NativeSkin^®, an immunocompetent skin model to study antigen uptake

14 October 2024

...

POSTER – CBD in skin care: impacts of time & tissue model

14 October 2024

...

FACT SHEET – HypoSkin^®, live & biostabilized human skin model

8 October 2024

...

POSTER – Injection local inflammatory reaction IID2018

8 October 2024

...

POSTER – Evaluation of vaccine potency with high-dimensional immune profiling using an innovative bio-stabilized human skin model

7 October 2024

...

WEBINAR #8 – Skin Response to mRNA Vaccine Injection – Manon Scholaert

20 September 2024

...

Systems Vaccinology

10 September 2024

...

VIDEO – Tutorial intradermal injection in HypoSkin^®

4 September 2024

With this video tutorial, you will learn step by step how to perform intradermal injections in our HypoSkin^® models. ...

VIDEO – Tutorial subcutaneous injection in HypoSkin^®

4 September 2024

With this video tutorial, you will learn step by step how to perform subcutaneous injections in our HypoSkin^® models. ...

USER MANUAL – NativeSkin^®

4 September 2024

The User Manual includes detailed descriptions of the NativeSkin^® model, available formats, and a step-by-step guide for kit use. ...

VIDEO – VaxSkin Tech Talk

3 September 2024

Discover VaxSkin's features and its real-world applications with this video presented by our CSO at the World Vaccine Congress Europe. ...

POSTER – High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin

20 August 2024

...

Accelerating vaccine development with transcriptomics

8 August 2024

...

Injection-Site Pain

22 July 2024

...

Immunogenicity series: Evaluating and managing immunogenicity for vaccines

12 July 2024

...

A unique human skin model to study subcutaneous injections

8 July 2024

...

PROTOCOL – Subcutaneous injection

2 July 2024

...

PROTOCOL – Intradermal injection

2 July 2024

...

APPLICATION NOTE – HypoSkin^® services

28 June 2024

HypoSkin services combine an ex vivo skin platform with new generation transcriptomic, cytokine analysis and bioinformatics to support your R&D with ...

Understanding neurogenic inflammation

26 June 2024

...

USER MANUAL – HypoSkin^®

26 June 2024

The User Manual includes detailed descriptions of the HypoSkin^® model, available formats, and a step-by-step guide for kit use. ...

FACT SHEET – In vitro mast cells

12 June 2024

Unlock the potential of mast cell research with Genoskin’s In Vitro Human Mast Cell Services for Drug Development. ...

CASE STUDY – Cetrorelix & ISR

12 June 2024

Discover how the ImmunoSafe: ISR Platform^® support the evaluation of local immune reactions caused by subcutaneous administration of ...

APPLICATION NOTE – ISR

12 June 2024

Explore how the ISR Platform^® can effectively de-risk your injectable therapeutic candidates today! ...

APPLICATION NOTE – Non clinical toxicity services

12 June 2024

Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin. ...

Ask the Expert: Your top questions about Genoskin’s mast cell platform answered

21 May 2024

...

Injection site reactions platform

16 May 2024

...

Unwanted immunogenicity

2 May 2024

...

Investigative toxicology

16 April 2024

...

WEBINAR #7 – Naked Immunology – Mast Cells – Marcus Maurer

13 March 2024

...

The silent crisis in biomedical research: beyond macaques

29 February 2024

...

Immunogenicity series: Wanted immunogenicity for vaccine development

29 February 2024

...

Understanding local tolerance

9 February 2024

...

Immunogenicity series: Defining immunogenicity

10 January 2024

...

The role of animal-free non-clinical platforms in drug development – Part 2

31 October 2023

...

The role of animal-free non-clinical platforms in drug development – Part 1

6 October 2023

...

PRESS RELEASE – ImmunoSafe: ISR Platform®

3 October 2023

Genoskin, a biotechnology company at the forefront of accelerating drug development, proudly announces the enhancement of its ISR ...

WEBINAR #6 Naked Immunology – Kinoid Vaccines for Allergic Diseases – Laurent Reber

27 September 2023

...

PRESS RELEASE- MANTIS data published in Science Advances

8 June 2023

Genoskin is proud to announce the publication of a groundbreaking scientific article in Science Advances, introducing a new analytic pipeline called ...

WEBINAR #5 Naked Immunology – Epithelial Barrier Theory – Cezmi Akdis

7 June 2023

...

Why testing and mitigating Injection Site Reactions is critical during drugs/vaccines development ?

25 April 2023

...

PRESS RELEASE – Genoskin and PharmaJet announce strategic research partnership to advance precision vaccine delivery

1 April 2023

Genoskin, a leading Franco-American TechBio company specializing in bio-stabilized immunocompetent human skin platforms, and PharmaJet, an innovative ...

WEBINAR #4 Naked Immunology – Science behind epidermal and dermal vaccination – Behazine Combadière

24 January 2023

...

WEBINAR #3 Naked Immunology- Neuroimmune regulation of itch – Brian Kim

19 September 2022

...

Human skin to predict clinical outcomes

31 August 2022

...

Immunocompetent human skin for vaccine and drug development

31 May 2022

...

PRESS RELEASE – Dr. Ginhoux joins Genoskin Scientific Advisory Board

12 May 2022

Genoskin is thrilled to welcome Dr. Florent Ginhoux, PhD, to its Scientific Advisory Board (SAB). After last year’s nomination of world-renowned ...

WEBINAR #2 Naked Immunology – Myeloid Cell Profiling – Florent Ginhoux

27 April 2022

...

WEBINAR #1 – MRGPRX2+ Mast Cells – Nicolas Gaudenzio

18 February 2022

...

What I Learned In A French Lab That Led To My Role As A CEO

11 February 2022

...

Better technology for reliable drug development

3 January 2022

...

PRESS RELEASE – Genoskin launches spatial skin biology platform MANTIS^®

6 December 2021

Genoskin launches MANTIS^®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS^® (Multiplex ANnotated ...

PRESS RELEASE – Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin

8 November 2021

Dr. Gaudenzio is a world-renowned researcher and expert in immunology and allergic skin inflammation. He is also principal investigator and leader of ...

De-risking antiaging trials with ex vivo skin models

28 October 2021

...

PRESS RELEASE – Genoskin launches the ISR platform^®

6 July 2021

Genoskin announces the launch of the ISR platform^®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ...

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

15 June 2021

...

Using NativeSkin® to study poison ivy-induced dermatitis

22 February 2021

...

Human connective tissue mast cells

30 November 2020

...

PRESS RELEASE – Genoskin launches new offering: NativeSkin access

4 September 2020

Genoskin, a biotechnology company developing ready-to-use human skin biopsies for ex vivo clinical testing, announces today the launch of its newest ...